VANCOUVER, March 23rd, 2020 – Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today a message from the CEO and Chairman of Aequus, Doug Janzen: “We have been working diligently over the past weeks to respond promptly and proactively against this novel coronavirus (COVID-19) and closely following the guidance of medical officials as well as the most recent government actions across several provinces. We have suspended in-field clinic ...
[ more ]
